Could Fibroblast Activation Protein (FAP)-Specific Radioligands Be Considered as Pan-Tumor Agents?

Figure 2

OR, risk differences and related heterogeneity indices of detection rates of radiolabeled FAPI guided and ¹⁸F-FDG directed PET/CT scans for different cancers in primary tumor as well as lymph node and distant metastases.